Number of the records: 1  

Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG

  1. 1.
    SYSNO0360711
    TitlePoint mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG
    Author(s) Mertlíková-Kaiserová, Helena (UOCHB-X) [980/98] RID, ORCID
    Rumlová, Michaela (UOCHB-X) [240/24] RID
    Tloušťová, Eva (UOCHB-X) [980/98] RID, ORCID
    Procházková, Eliška (UOCHB-X) [980/98] RID, ORCID
    Holý, Antonín (UOCHB-X) [310/31]
    Votruba, Ivan (UOCHB-X) [980/98] RID
    Source Title Biochemical Pharmacology. Roč. 82, č. 2 (2011), s. 131-138. - : Elsevier
    Document TypeČlánek v odborném periodiku
    Grant 1M0508 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    CEZAV0Z40550506 - UOCHB-X (2005-2011)
    Languageeng
    CountryUS
    Keywords resistance * acyclic nucleoside phosphonates * PMEG * PMEDAP
    Permanent Linkhttp://hdl.handle.net/11104/0198197
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.